Understanding and addressing lung cancer risks in Native Hawaiians.
Project 2: Mitigating Lung Cancer Disparities in Native Hawaiians: A Population-Based Approach to Evaluate Prevention Barriers and Lung Tumor Biology
This study is looking at why Native Hawaiians have a higher risk of lung cancer and worse survival rates compared to others, and it aims to find ways to improve early detection and prevention, especially through low-dose CT scans, by understanding the unique challenges this community faces.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Hawaii at Manoa NIH-funded |
| Lab location | 1 site (Honolulu, United States) |
| Project ID | NIH-10931598 on NIH RePORTER |
What this research studies
This research investigates the higher risk and poorer survival rates of lung cancer among Native Hawaiians compared to other populations. It focuses on identifying barriers to lung cancer prevention and screening, particularly the use of low-dose Computed Tomography (LDCT) for early detection. The study will analyze genetic, epigenetic, and behavioral factors that contribute to these disparities, aiming to improve lung cancer outcomes in this community. By engaging with the local population, the research seeks to develop tailored interventions that address specific needs and challenges.
Who could benefit from this research
Good fit: Ideal candidates for this research include Native Hawaiians aged 50 to 80 years with a history of smoking or those who have quit within the past 15 years.
Not a fit: Patients who do not identify as Native Hawaiians or do not meet the age and smoking history criteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved lung cancer prevention and early detection strategies for Native Hawaiians, ultimately enhancing survival rates.
How similar studies have performed: Previous research has successfully identified disparities in lung cancer risk among different populations, suggesting that targeted approaches can lead to meaningful improvements in health outcomes.
Where this research is happening
Honolulu, United States
- University of Hawaii at Manoa — Honolulu, United States (Active)
Researchers
- Principal investigator: Park, Sungshim Lani — University of Hawaii at Manoa
- Study coordinator: Park, Sungshim Lani
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.